𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Current Management of HBV Antiviral Drug Resistance

✍ Scribed by Pietro Lampertico; Mauro Viganò; Massimo Colombo


Book ID
107540567
Publisher
Current Science Inc.
Year
2011
Tongue
English
Weight
172 KB
Volume
10
Category
Article
ISSN
1540-3416

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Antiviral drug-resistant HBV: Standardiz
✍ Anna S. Lok; Fabien Zoulim; Stephen Locarnini; Angeline Bartholomeusz; Marc G. G 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB

Substantial advances have been made in the treatment of chronic hepatitis B in the past decade. Approved treatments for chronic hepatitis B include 2 formulations of interferon and 4 nucleos(t)ide analogues (NAs). Sustained viral suppression is rarely achieved after withdrawal of a 48-week course of

Resistance of HBV to adefovir dipivoxil:
✍ Costica Aloman; Jack R. Wands 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

Background & Aims: Adefovir dipivoxil effectively inhibits both hepatitis B virus (HBV) replication and disease activity in patients with chronic hepatitis B. Resistance to treatment was not observed in 2 recent large placebo-controlled 48-week studies with this drug. The aim of this study was to ch